“Keros Therapeutics Inc. Under Investigation by Shareholder Rights Advocates: Investors Urged to Contact Levi and Korsinsky for Potential Securities Law Violations (KROS)”
Levi & Korsinsky Investigates Keros Therapeutics, Inc. for Securities Law Violations Investigation Announcement On January 21, 2025, Levi & Korsinsky announced that they have initiated an investigation into Keros Therapeutics, Inc. (NASDAQ:KROS) for potential violations of federal securities laws. This investigation comes in response to a press release issued by Keros on December 12, 2024,…